PURPOSE: We aim to analyse the relationship between the quality of information during the decision-making process regarding surgery to treat high-grade gliomas and the level of anxiety of the patients. METHODS: This is a transversal, descriptive and correlational study on 26 patients with a clinical and radiological diagnosis of high-grade glioma. They scored the quality (in terms of comprehension and satisfaction) of information received about the treatment options and prognosis during the surgical decision-making process, and the Hospital Anxiety and Depression Scale questionnaire (HADS) was applied immediately afterward. RESULTS: Lower levels of anxiety were observed in patients who showed a desire to receive information regarding their illness, those with a higher degree of comprehension, and those with a higher level of satisfaction with the information provided. CONCLUSIONS: An improvement in the communication process contributes to a decrease in the levels of anxiety, and consequently to enhancement of the well-being of these patients.
PURPOSE: We aim to analyse the relationship between the quality of information during the decision-making process regarding surgery to treat high-grade gliomas and the level of anxiety of the patients. METHODS: This is a transversal, descriptive and correlational study on 26 patients with a clinical and radiological diagnosis of high-grade glioma. They scored the quality (in terms of comprehension and satisfaction) of information received about the treatment options and prognosis during the surgical decision-making process, and the Hospital Anxiety and Depression Scale questionnaire (HADS) was applied immediately afterward. RESULTS: Lower levels of anxiety were observed in patients who showed a desire to receive information regarding their illness, those with a higher degree of comprehension, and those with a higher level of satisfaction with the information provided. CONCLUSIONS: An improvement in the communication process contributes to a decrease in the levels of anxiety, and consequently to enhancement of the well-being of these patients.
Authors: Adam M Robin; Tobias Walbert; Tom Mikkelsen; Steven N Kalkanis; Jack Rock; Ian Lee; Mark L Rosenblum Journal: J Neurooncol Date: 2014-07-16 Impact factor: 4.130
Authors: A J Applebaum; K Buda; M Kryza-Lacombe; J J Buthorn; R Walker; K M Shaffer; T A D'Agostino; E L Diamond Journal: Psychooncology Date: 2017-12-19 Impact factor: 3.894
Authors: Eli L Diamond; Geoffrey W Corner; Antonio De Rosa; William Breitbart; Allison J Applebaum Journal: J Neurooncol Date: 2014-05-30 Impact factor: 4.130
Authors: Eli L Diamond; David Russell; Maria Kryza-Lacombe; Kathryn H Bowles; Allison J Applebaum; Jeanne Dennis; Lisa M DeAngelis; Holly G Prigerson Journal: Neuro Oncol Date: 2015-08-09 Impact factor: 12.300
Authors: Eli L Diamond; Holly G Prigerson; Denise C Correa; Anne Reiner; Katherine Panageas; Maria Kryza-Lacombe; Justin Buthorn; Elizabeth C Neil; Alex M Miller; Lisa M DeAngelis; Allison J Applebaum Journal: Neuro Oncol Date: 2017-10-19 Impact factor: 12.300